A 62-year-old woman with chronic atrial fibrillation is started on amiodarone for rate control. After 3 months of therapy, she develops tremor, ataxia, and cognitive slowing. Which of the following best explains the mechanism of this adverse effect?

Question

Accepted Answer

C. Accumulation in the cerebellum and brainstem causing neurotoxicity. ## Mechanism of Amiodarone Neurotoxicity

### Clinical Presentation
The triad of tremor, ataxia, and cognitive slowing in a patient on chronic amiodarone represents **amiodarone-induced neurotoxicity**, a well-documented but often underrecognized adverse effect.

### Why Option 1 (Hypothyroidism) Is Incorrect
While amiodarone does inhibit thyroid peroxidase and cause hypothyroidism (due to its high iodine content), hypothyroidism typically presents with:
  - Fatigue, weight gain, cold intolerance
  - Bradycardia, delayed reflexes
  - Elevated TSH and low free T4

The neurological triad described—tremor, ataxia, and cognitive slowing—is NOT the classic presentation of hypothyroidism and occurs independently of thyroid dysfunction in amiodarone users.

### Correct Mechanism: Cerebellar and Brainstem Accumulation

**Key Point:** Amiodarone is highly lipophilic and accumulates in lipid-rich tissues, including the cerebellum and brainstem.

Amiodarone's neurotoxicity arises from:

1. **Lipophilic nature** — The drug crosses the blood-brain barrier readily
2. **Tissue accumulation** — Preferential deposition in:
   - Cerebellum (causing ataxia and tremor)
   - Brainstem (contributing to cognitive and motor effects)
3. **Chronic toxicity** — Symptoms emerge after months of therapy as drug levels accumulate
4. **Mechanism of injury** — Likely involves:
   - Mitochondrial dysfunction
   - Oxidative stress
   - Phospholipidosis (accumulation of phospholipid-drug complexes)

**Clinical Pearl:** Amiodarone neurotoxicity is dose- and duration-dependent. It is reversible if the drug is discontinued early, but may persist if exposure continues.

### Differential Features

| Feature | Amiodarone Neurotoxicity | Hypothyroidism | GABA Blockade |
|---------|-------------------------|-----------------|---------------|
| **Onset** | Months of therapy | Insidious | Acute/subacute |
| **Tremor** | Fine, prominent | Rare | Coarse |
| **Ataxia** | Cerebellar | Absent | Possible but rare |
| **Cognitive change** | Slowing, confusion | Slowing, lethargy | Seizures, agitation |
| **Reversibility** | Partial/slow | Complete with replacement | Rapid with reversal |

### High-Yield Points

**High-Yield:** Amiodarone neurotoxicity is a class effect of highly lipophilic antiarrhythmics. Other lipophilic drugs (e.g., chloroquine, tamoxifen) show similar CNS accumulation patterns.

**Warning:** Do not conflate amiodarone's thyroid effects with its neurological toxicity—they are independent adverse effects. A patient may have normal thyroid function yet develop neurotoxicity, or vice versa.

[cite:Harrison 21e Ch 226]

Answer

A. Displacement of warfarin from plasma protein binding

Answer

B. Blockade of GABA receptors in the central nervous system

Answer

D. Inhibition of thyroid peroxidase leading to hypothyroidism

A 62-year-old woman with chronic atrial fibrillation is started on amiodarone for rate control. After 3 months of therapy, she develops tremor, ataxia, and cognitive slowing. Which of the following best explains the mechanism of this adverse effect?

Explanation

Mechanism of Amiodarone Neurotoxicity

Clinical Presentation

Why Option 1 (Hypothyroidism) Is Incorrect

Correct Mechanism: Cerebellar and Brainstem Accumulation

Differential Features

High-Yield Points

Practice similar questions

Join our NEET PG community

Feature	Amiodarone Neurotoxicity	Hypothyroidism	GABA Blockade
Onset	Months of therapy	Insidious	Acute/subacute
Tremor	Fine, prominent	Rare	Coarse
Ataxia	Cerebellar	Absent	Possible but rare
Cognitive change	Slowing, confusion	Slowing, lethargy	Seizures, agitation
Reversibility	Partial/slow	Complete with replacement	Rapid with reversal